Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Novavax, Inc. (NVAX) - free report >>
Braskem S.A. (BAK) - free report >>
Potbelly Corporation (PBPB) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Novavax, Inc. (NVAX) - free report >>
Braskem S.A. (BAK) - free report >>
Potbelly Corporation (PBPB) - free report >>
Image: Bigstock
New Strong Buy Stocks for January 28th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Potbelly Corporation (PBPB - Free Report) : This franchise company has seen the Zacks Consensus Estimate for its current year earnings increasing 14.3% over the last 60 days.
Potbelly Corporation Price and Consensus
Potbelly Corporation price-consensus-chart | Potbelly Corporation Quote
Concrete Pumping Holdings, Inc. (BBCP - Free Report) : This concrete pumping and waste management services provider has seen the Zacks Consensus Estimate for its current year earnings increasing 38.7% over the last 60 days.
CONCRETE PUMPING HOLDINGS, INC. Price and Consensus
CONCRETE PUMPING HOLDINGS, INC. price-consensus-chart | CONCRETE PUMPING HOLDINGS, INC. Quote
Braskem S.A. (BAK - Free Report) : This thermoplastic resin company has seen the Zacks Consensus Estimate for its current year earnings increasing 41.9% over the last 60 days.
Braskem S.A. Price and Consensus
Braskem S.A. price-consensus-chart | Braskem S.A. Quote
Novavax, Inc. (NVAX - Free Report) : This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 6.4% over the last 60 days.
Novavax, Inc. Price and Consensus
Novavax, Inc. price-consensus-chart | Novavax, Inc. Quote
Eton Pharmaceuticals, Inc. (ETON - Free Report) : This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.
Eton Pharmaceuticals, Inc. Price and Consensus
Eton Pharmaceuticals, Inc. price-consensus-chart | Eton Pharmaceuticals, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.